InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,270.55
(
-0.13%
)
US TECH 100
18,064.00
(
0.20%
)
Dow Jones
38,437.51
(
-0.64%
)
Brent Oil
78.41
(
-2.97%
)
Bitcoin
69,216.01
(
2.16%
)
Post# of 252014
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

maverick_1

Send PM Follow Ignore
Followers 114
Posts 2958
Boards Moderated 0
Alias Born 06/28/2014

maverick_1

Re: maverick_1 post# 212354

Wednesday, 07/12/2017 5:12:37 PM

Wednesday, July 12, 2017 5:12:37 PM

Post# of 252014
Reuters AND John Carroll formerly of FierceBiotech and now Endpoints on AZN's CEO:

[Israel-based Teva Pharmaceutical Industries (TEVA.TA) is expected to name Anglo-Swedish group AstraZeneca's (AZN.L) Chief Executive Pascal Soriot as Teva's next CEO, the Calcalist financial news website said on Wednesday.

Soriot has met with Teva's (TEVA.N) search committee and its chairman and expressed his agreement to serve as its next CEO, Calcalist said.quote]

http://www.reuters.com/article/us-teva-pharm-ind-astrazeneca-ceo-idUSKBN19X2OB?il=0

https://endpts.com/israeli-newspaper-reports-that-astrazeneca-ceo-pascal-soriot-has-agreed-to-take-the-helm-at-teva/

DIFFERENT STROKES FOR DIFFERENT FOLKS


















DIFFERENT STROKES FOR DIFFERENT FOLKS

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up